Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

SAN FRANCISCO, Jan 12 (Reuters) - Eli Lilly's research and development head said on Monday the company will have plenty of ...

You know how true the above statement is, especially if you’ve struggled with your weight most of your life. What you might ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

A large review found that people who stopped taking GLP-1 drugs regained weight nearly twice as fast as people who gave up ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to ...

One simple thing could prevent people using the ‘miracle’ drugs from sustaining long-term health consequences.

Weight loss journeys are as unique as the individuals who embark on them. We all have different body types, lifestyles, health histories and goals that shape what we need to achieve lasting results.

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.